COMPOSITIONS FOR DRG-SPECIFIC REDUCTION OF TRANSGENE EXPRESSION Application EP-4048785-A4 European Patent Office 27 Mar 2024
AAV9-mediated gene therapy for treating mucopolysaccharidosis type I Grant US-11890329-B2 United States of America 06 Feb 2024
Gene therapy for treating Mucopolysaccharidosis type II Grant US-11819539-B2 United States of America 21 Nov 2023
GNAO1 GENE THERAPY VECTORS AND USES THEREOF Application WO-2023102518-A1 World Intellectual Property Organisation (WIPO) 08 Jun 2023